ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

Coding Corner Question: November

Staff  |  November 1, 2012

Test your knowledge of the level of medical decision making (MDM) for an evaluation and management (E/M) office visit of a patient whose rheumatoid arthritis is worse on chronic medicine, whose osteoporosis is stable on chronic medicine, and who presents with a new problem of elevated blood pressure (BP)

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodingE&MEvaluation and ManagementimagingOsteoporosisPractice ManagementRheumatoid arthritisrheumatologist

Coding Corner Answer: November Coding Challenge

Staff  |  November 1, 2012

Coding for medical decision making in the evaluation and management (E/M) for assessment and treatment of rheumatoid arthritis, osteoporosis, and elevated blood pressure

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingE&MEvaluation and ManagementimaginglabsPractice Managementrheumatologist

Healthcare Professionals Find Benefits in Specialized Rheumatology Training Course

Ann Kepler  |  November 1, 2012

Enhanced caregiver-patient interactions, patient evaluations, patient education, and practice productivity are considered positive outcomes of the American College of Rheumatology’s (ACR) Advanced Rheumatology Course (ARC)

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:AC&RAmerican College of Rheumatology (ACR)EducationrheumatologistTraining

Drug Updates: Lorcaserin, Acetaminophen, and More

Michele B. Kaufman, PharmD, BCGP  |  September 5, 2012

information on new approvals and medication safety

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisRheumatoid Arthritis Tagged with:acetaminophenAnkylosing SpondylitisApprovalsBiologicsdrugFDAPipelinepsoriatic arthritisrituximabSafetySteroids

Rheumatology Clinical Registry Integrates AIM:RA

Staff  |  July 9, 2012

AIM:RA is a web-based self-evaluation of practice performance tool designed to guide a physician through medical-chart data abstraction using a series of questions related directly to evidence-based quality indicators.

Filed under:Career DevelopmentCertificationConditionsFrom the CollegeInformation TechnologyPractice SupportProfessional TopicsQuality Assurance/ImprovementRheumatoid ArthritisTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)CertificationMedicareMOCpractice performancequality improvementRheumatoid arthritisrheumatologistTechnology

California Rheumatologists Explore Managed Care, Treatment Options

Larry Beresford  |  July 9, 2012

Advances in SLE, osteoporosis, and RA highlighted at California Rheumatology Alliance meeting.

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyOsteoarthritis and Bone DisordersProfessional TopicsResearch Rheum Tagged with:ACAAffordable Care Act (ACA)BiologicsdrugHealthcare ReformLegislationLupusmanaged careMedicareOsteoporosispatient careradiographResearchRheumatoid arthritisrheumatologistSystemic lupus erythematosus

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 9, 2012

Information on new approvals and medication safety.

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Ankylosing SpondylitisBiologicsbiophosphonatesdrugJAK inhibitorsjanus kinaseMethotrexateopioidPainRheumatoid arthritisrheumatologistrituximabSafetySystemic lupus erythematosustocilizumabTofacitinib

Medication Quick Guides Offer Infusion Staff a Streamlined Resource

Susan Richmond, MS, PA-C; Karla B. Jones, RN, MS, CPNP  |  June 10, 2012

The ACR/ARHP Medication Quick Guides offer easily accessable pharmaceutical information to rheumatologists.

Filed under:Biologics/DMARDsDrug UpdatesFrom the College Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiologicsdrugpharmacyresourceSafety

Systemic Juvenile Idiopathic Arthritis

Rayfel Schneider, MBBCh, and Ronald M. Laxer, MDCM  |  May 9, 2012

Changing treatment paradigms in the biologic era

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatorydrugJIAJuvenile idiopathic arthritismacrophage activation syndromeMethotrexatepatient carePediatricsrheumatologistSteroidstocilizumabTreatment

Drug Updates: Citalopram hydrobromide, Statins, and More

Michele B. Kaufman, PharmD, BCGP  |  May 8, 2012

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:ApprovalsBiologicsdrugJAK inhibitorsjanus kinasePipelineRheumatoid arthritisSafetyStatin

  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 59
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences